Quantbot Technologies’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,100
Closed -$23.2K 2075
2023
Q2
$23.2K Buy
+2,100
New +$29.3K ﹤0.01% 1402
2022
Q2
Sell
-997
Closed -$16K 2257
2022
Q1
$16K Sell
997
-1,571
-61% -$24.6K ﹤0.01% 1410
2021
Q4
$41K Buy
+2,568
New +$43.3K ﹤0.01% 1080
2021
Q2
Sell
-55
Closed -$1K 1980
2021
Q1
$1K Sell
55
-1,941
-97% -$54.1K ﹤0.01% 1354
2020
Q4
$49K Buy
1,996
+400
+25% +$13.3K 0.01% 863
2020
Q3
$66K Buy
1,596
+1,437
+904% +$66K 0.01% 806
2020
Q2
$7K Sell
159
-8
-5% -$618 ﹤0.01% 977
2020
Q1
$10K Buy
167
+38
+29% +$3.42K 0.01% 691
2019
Q4
$15K Buy
129
+23
+22% +$2.06K ﹤0.01% 1080
2019
Q3
$7K Buy
106
+6
+6% +$403 ﹤0.01% 1194
2019
Q2
$7K Buy
+100
New +$8.95K ﹤0.01% 1112
2017
Q3
Sell
-867
Closed -$104K 1487
2017
Q2
$104K Sell
867
-643
-43% -$74.5K 0.01% 792
2017
Q1
$170K Buy
+1,510
New +$176K 0.02% 659
2016
Q2
Sell
-835
Closed -$107K 1429
2016
Q1
$107K Sell
835
-1,028
-55% -$121K 0.02% 710
2015
Q4
$278K Buy
+1,863
New +$315K 0.05% 381
2014
Q2
Sell
-100
Closed -$32K 1441
2014
Q1
$32K Buy
+100
New +$33.7K 0.01% 888

Other funds holding ICPT

Quantbot Technologies's ICPT Position: Q3 2023 in Review

Quantbot Technologies sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 2,100 shares — an estimated $23.2K sold.

Quantbot Technologies first reported a position in ICPT in Q1 2014 and held it in 16 quarters. The position peaked at $278K in Q4 2015. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • Quantbot Technologies reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Quantbot Technologies sold 2,100 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $23.2K.
  • Quantbot Technologies first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 16 quarters.
  • Quantbot Technologies's Intercept Pharmaceuticals, Inc. position peaked at $278K in Q4 2015.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Quantbot Technologies's 13F filing for Q3 2023, filed 7 Nov 2023.